血阿尔茨海默病生物标志物如何反映CSF粉样蛋白状况?
Jemma Hazan1, Emily Abel2, Miguel Rosa Grilo3
1Division of Psychiatry, UCL, London, UK j.hazan@ucl.ac.uk.
Journal of neurology, neurosurgery, and psychiatry
|December 18, 2024
概括
像p-tau217这样的等离子体生物标志物通过区分粉样β-阳性和负组来诊断阿尔茨海默病的可能性很大,尽管在老年人中性能略有下降.
科学领域:
- 在神经退行性疾病中发现生物标志物
- 脑脊液 (CSF) 和血分析分析
- 阿尔茨海默病的诊断阿尔茨海默病的诊断.
背景情况:
- 评估血生物标志物与脑脊液 (CSF) 的实用性,以区分粉样β-阳性 (Aβ+) 和粉样β-阴性 (Aβ-) 个体.
- 在英国认知障碍诊所设置中,调查典型年龄段的生物标志物性能.
研究的目的:
- 评估血生物标志物在区分Aβ+和Aβ-组的诊断准确性.
- 评估年龄对这些血生物标志物的表现的影响.
主要方法:
- 分析了111名患者的血液和脑脊液样本.
- 根据CSF Aβ42/40比率对Aβ+和Aβ-组进行分类.
- 对四种Quanterix Simoa血分析样本的评估:p-tau217,p-tau217/Aβ42比率,p-tau181,p-tau181/Aβ42比率和Aβ42/40比率.
主要成果:
- 血p-tau217表现出高的诊断准确性 (AUC=0.94),p-tau217/Aβ42比率达到0.97.7的AUC.
- 血Aβ42/40 (AUC=0.78) 和p-tau181 (AUC=0.77) 的区分能力较差.
- 年龄对生物标志物的表现产生了负面影响,老年人的分离减少 (p-tau217和p-tau217/Aβ42比率的显著相互作用).
结论:
- 血p-tau217和p-tau217/Aβ42比率显示出作为CSF粉样蛋白状态的可靠替代品的显著潜力.
- 这些有前途的生物标志物的性能在老年人群中略有下降.
- 需要进一步的研究,以解决与年龄相关的混因素在血生物标志物的准确性.
相关概念视频
01:26Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444
01:22Alzheimer's Disease: Treatment
162
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
162
03:03Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K